1 / 30
文档名称:

欧美高血压指南.ppt

格式:ppt   大小:1,228KB   页数:30页
下载后只包含 1 个 PPT 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

欧美高血压指南.ppt

上传人:落意心 2022/4/12 文件大小:1.20 MB

下载得到文件列表

欧美高血压指南.ppt

相关文档

文档介绍

文档介绍:欧美高血压指南
英国高血压指南
血压测量
高血压标准:>140/90mmHg;
24小时动态血压或家庭血压>135/85mmHg。
心血管病风险评估(Framingham计分)
10年CVD危险分层:高危≥20ibitors
α1-Adrenoceptor antagonists
AT1 receptor antagonists
Central SNS modulators
β-Adrenoceptor antagonists
Calcium channel antagonists (non-DHP)
ACE inhibitors
α1-Adrenoceptor antagonists
AT1 receptor antagonists
β-Adrenoceptor antagonists
Diuretics (thiazide or loop)
α1-Adrenoceptor antagonists
Calcium channel antagonists (DHP)
Thiazide diuretics
ACE inhibitors
α1-Adrenoceptor antagonists
AT1 receptor antagonists
Central SNS modulators
β-Adrenoceptor antagonistsa
Table II. Rational combinations of antihypertensive drugs
高血压结合用药推荐分为3类情况
优先选择(preferred)
可以接受(acceptable)
缺乏效果(less effective)
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; CCB, calcium channel blocker. aSingle-pill combinations available in the United States.
Preferred
ACE inhibitor/diuretica
ARB/diuretica
ACE inhibitor/CCBa
ARB/CCBa
Acceptable
β-Blocker/diuretica
CCB (dihydropyridine)/β-blocker
CCB/diuretic
Renin inhibitor/diuretica
Renin inhibitor/ARBa
Thiazide diuretics/K+-sparing diureticsa
Less effective
ACE inhibitor/ARB
ACE inhibitor/β-blocker
ARB/β-blocker
CCB (nondihydropyridine)/β-blocker
Centrally acting agent/β-blocker
2019ACCF/AHA美国老年高血压共识要点
老年高血压特征(见下表)
脉压与CHD关系(见下表)
动脉僵硬与血管适应性改变(见下表)
Figure 4 Frequency of Untreated Hypertension According to Subtype and Age
Figure 5 Joint Influences of Systolic Blood Pressure and Pulse Pressure
on Coronary Heart Disease
Figure 7 Conceptual Framework for Cardiovascular Adaptations to
Arterial Stiffening That Occur With Aging
动脉僵硬相关改变
体位性低血压
假性高血压—Osler征
脉动性肾病
脉动性脑病(见下表)
脉动性缺血性心脏病(见下表)
Figure 8 Absolute Risk of Stroke Mortality in Relation to Blood Pressure
Figure 11 Absolute Risk of Ischemic Heart Disease Mortality
in Relation to Blood Pressure
Figure 2 Extent of Awareness, Treatment,